These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 27357419)

  • 1. miR-20a induces cisplatin resistance of a human gastric cancer cell line via targeting CYLD.
    Zhu M; Zhou X; Du Y; Huang Z; Zhu J; Xu J; Cheng G; Shu Y; Liu P; Zhu W; Wang T
    Mol Med Rep; 2016 Aug; 14(2):1742-50. PubMed ID: 27357419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-20a enhances cisplatin resistance of human gastric cancer cell line by targeting NFKBIB.
    Du Y; Zhu M; Zhou X; Huang Z; Zhu J; Xu J; Cheng G; Shu Y; Liu P; Zhu W; Wang T
    Tumour Biol; 2016 Jan; 37(1):1261-9. PubMed ID: 26286834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYLD downregulates Livin and synergistically improves gemcitabine chemosensitivity and decreases migratory/invasive potential in bladder cancer: the effect is autophagy-associated.
    Yin L; Liu S; Li C; Ding S; Bi D; Niu Z; Han L; Li W; Gao D; Liu Z; Lu J
    Tumour Biol; 2016 Sep; 37(9):12731-12742. PubMed ID: 27448305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-362 induces cell proliferation and apoptosis resistance in gastric cancer by activation of NF-κB signaling.
    Xia JT; Chen LZ; Jian WH; Wang KB; Yang YZ; He WL; He YL; Chen D; Li W
    J Transl Med; 2014 Feb; 12():33. PubMed ID: 24495516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-503 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R and BCL2.
    Wang T; Ge G; Ding Y; Zhou X; Huang Z; Zhu W; Shu Y; Liu P
    Chin Med J (Engl); 2014; 127(12):2357-62. PubMed ID: 24931256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-200c regulates cisplatin resistance by targeting ZEB2 in human gastric cancer cells.
    Jiang T; Dong P; Li L; Ma X; Xu P; Zhu H; Wang Y; Yang B; Liu K; Liu J; Xue J; Lv R; Su P; Kong G; Chang Y; Zhao C; Wang L
    Oncol Rep; 2017 Jul; 38(1):151-158. PubMed ID: 28534959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7.
    Zhou X; Jin W; Jia H; Yan J; Zhang G
    J Exp Clin Cancer Res; 2015 Mar; 34(1):28. PubMed ID: 25888377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-500 sustains nuclear factor-κB activation and induces gastric cancer cell proliferation and resistance to apoptosis.
    Zhang L; Ding Y; Yuan Z; Liu J; Sun J; Lei F; Wu S; Li S; Zhang D
    Oncotarget; 2015 Feb; 6(4):2483-95. PubMed ID: 25595906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-149 reverses cisplatin resistance of gastric cancer SGC7901/DDP cells by targeting FoxM1.
    Li X; Liang J; Liu YX; Wang Y; Yang XH; Luan BH; Zhang GL; Du J; Wu XH
    Pharmazie; 2016 Nov; 71(11):640-643. PubMed ID: 29441968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of c-Myc by let-7b mimic reverses mutidrug resistance in gastric cancer cells.
    Yang X; Cai H; Liang Y; Chen L; Wang X; Si R; Qu K; Jiang Z; Ma B; Miao C; Li J; Wang B; Gao P
    Oncol Rep; 2015 Apr; 33(4):1723-30. PubMed ID: 25633261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2.
    Yang M; Shan X; Zhou X; Qiu T; Zhu W; Ding Y; Shu Y; Liu P
    Anticancer Agents Med Chem; 2014; 14(6):884-91. PubMed ID: 24875127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of microRNA-34a enhances the DDP sensitivity of gastric cancer cells by modulating proliferation and apoptosis via targeting MET.
    Zhang Z; Kong Y; Yang W; Ma F; Zhang Y; Ji S; Ma EM; Liu H; Chen Y; Hua Y
    Oncol Rep; 2016 Oct; 36(4):2391-7. PubMed ID: 27513895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene.
    Wang TS; Ding QQ; Guo RH; Shen H; Sun J; Lu KH; You SH; Ge HM; Shu YQ; Liu P
    Biomed Pharmacother; 2010 May; 64(5):333-8. PubMed ID: 19914791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reciprocal activation between STAT3 and miR-181b regulates the proliferation of esophageal cancer stem-like cells via the CYLD pathway.
    Xu DD; Zhou PJ; Wang Y; Zhang L; Fu WY; Ruan BB; Xu HP; Hu CZ; Tian L; Qin JH; Wang S; Wang X; Li YC; Liu QY; Ren Z; Zhang R; Wang YF
    Mol Cancer; 2016 May; 15(1):40. PubMed ID: 27189061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The reversing and molecular mechanisms of miR-503 on the drug-resistance to cisplatin in A549/DDP cells].
    Wu Y; Guo L; Liu J; Liu R; Liu M; Chen J
    Zhongguo Fei Ai Za Zhi; 2014 Jan; 17(1):1-7. PubMed ID: 24398307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR‑138‑5p modulates the expression of excision repair cross‑complementing proteins ERCC1 and ERCC4, and regulates the sensitivity of gastric cancer cells to cisplatin.
    Ning J; Jiao Y; Xie X; Deng X; Zhang Y; Yang Y; Zhao C; Wang H; Gu K
    Oncol Rep; 2019 Feb; 41(2):1131-1139. PubMed ID: 30535472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1.
    Yan R; Li K; Yuan DW; Wang HN; Zhang Y; Dang CX; Zhu K
    Int J Oncol; 2018 Dec; 53(6):2566-2578. PubMed ID: 30320337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long noncoding RNA CRAL reverses cisplatin resistance via the miR-505/CYLD/AKT axis in human gastric cancer cells.
    Wang Z; Wang Q; Xu G; Meng N; Huang X; Jiang Z; Chen C; Zhang Y; Chen J; Li A; Li N; Zou X; Zhou J; Ding Q; Wang S
    RNA Biol; 2020 Nov; 17(11):1576-1589. PubMed ID: 31885317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2.
    Bao J; Xu Y; Wang Q; Zhang J; Li Z; Li D; Li J
    Biomed Pharmacother; 2017 Aug; 92():1030-1037. PubMed ID: 28609840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line.
    Li JH; Luo N; Zhong MZ; Xiao ZQ; Wang JX; Yao XY; Peng Y; Cao J
    Tumour Biol; 2016 Feb; 37(2):2387-94. PubMed ID: 26376998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.